Overexpressing KV1.3 in tumor-specific T cells lowers intracellular K+ concentrations by increasing K+ efflux into the interstitial fluid and thereby improves the functioning of the effector T cells by increasing Akt-mTOR activation and the production of IFN-γ [92]. The gene discussed is KCNA3; the disease is neoplasm.